Found: 52
Select item for more details and to access through your institution.
Endoscopy-verified occult subependymal dissemination of glioblastoma and brain metastasis undetected by MRI: prognostic significance.
- Published in:
- OncoTargets & Therapy, 2012, v. 5, p. 449, doi. 10.2147/OTT.S39429
- By:
- Publication type:
- Article
Rare synchronous association of vestibular schwannoma and indolent insular oligodendroglioma in a patient without neurofibromatosis: controversial issue of timing for surgical treatment of asymptomatic low-grade gliomas.
- Published in:
- OncoTargets & Therapy, 2012, v. 5, p. 357, doi. 10.2147/OTT.S39276
- By:
- Publication type:
- Article
Cancer stem cells in head and neck cancer.
- Published in:
- OncoTargets & Therapy, 2012, v. 5, p. 375, doi. 10.2147/OTT.S38694
- By:
- Publication type:
- Article
Non-Hodgkin lymphoma and GIST: molecular pathways and clinical expressions.
- Published in:
- OncoTargets & Therapy, 2012, v. 5, p. 433, doi. 10.2147/OTT.S38645
- By:
- Publication type:
- Article
Abnormal expression of PER1 circadian-clock gene in oral squamous cell carcinoma.
- Published in:
- OncoTargets & Therapy, 2012, v. 5, p. 403, doi. 10.2147/OTT.S38508
- By:
- Publication type:
- Article
The impact of tumor size change after target therapy on survival: analysis of patients enrolled onto three clinical trials of advanced NSCLC from one institution.
- Published in:
- OncoTargets & Therapy, 2012, v. 5, p. 349, doi. 10.2147/OTT.S38441
- By:
- Publication type:
- Article
β-blockers: a novel class of antitumor agents.
- Published in:
- OncoTargets & Therapy, 2012, v. 5, p. 391, doi. 10.2147/OTT.S38403
- By:
- Publication type:
- Article
Impact of CHK2-small interfering RNA on CpG ODN7909-enhanced radiosensitivity in lung cancer A549 cells.
- Published in:
- OncoTargets & Therapy, 2012, v. 5, p. 425, doi. 10.2147/OTT.S38240
- By:
- Publication type:
- Article
Comparison of different methods for detecting epidermal growth factor receptor mutations in peripheral blood and tumor tissue of non-small cell lung cancer as a predictor of response to gefitinib.
- Published in:
- OncoTargets & Therapy, 2012, v. 5, p. 439, doi. 10.2147/OTT.S37289
- By:
- Publication type:
- Article
γ-H2AX expression detected by immunohistochemistry correlates with prognosis in early operable non-small cell lung cancer.
- Published in:
- OncoTargets & Therapy, 2012, v. 5, p. 309, doi. 10.2147/OTT.S36995
- By:
- Publication type:
- Article
Pegylated liposomal doxorubicin in malignant pleural mesothelioma: a possible guardian for long-term survival.
- Published in:
- OncoTargets & Therapy, 2012, v. 5, p. 231, doi. 10.2147/OTT.S36915
- By:
- Publication type:
- Article
Review of meta-analyses evaluating surrogate endpoints for overall survival in oncology.
- Published in:
- OncoTargets & Therapy, 2012, v. 5, p. 287, doi. 10.2147/OTT.S36683
- By:
- Publication type:
- Article
Prognostic significance of different immunohistochemical S100A2 protein expression patterns in patients with operable nonsmall cell lung carcinoma.
- Published in:
- OncoTargets & Therapy, 2012, v. 5, p. 363, doi. 10.2147/OTT.S36474
- By:
- Publication type:
- Article
Prognostic value of ferritin, neuron-specific enolase, lactate dehydrogenase, and urinary and plasmatic catecholamine metabolites in children with neuroblastoma.
- Published in:
- OncoTargets & Therapy, 2012, v. 5, p. 417, doi. 10.2147/OTT.S36366
- By:
- Publication type:
- Article
Prognostic significance of AKT/mTOR signaling in advanced neuroendocrine tumors treated with somatostatin analogs.
- Published in:
- OncoTargets & Therapy, 2012, v. 5, p. 409, doi. 10.2147/OTT.S36330
- By:
- Publication type:
- Article
Clinicopathological and prognostic significance of epithelial mesenchymal transition-related protein expression in intrahepatic cholangiocarcinoma.
- Published in:
- OncoTargets & Therapy, 2012, v. 5, p. 255, doi. 10.2147/OTT.S36213
- By:
- Publication type:
- Article
Tumor necrosis factor signaling is implicated in intestinal mucosal injury of cancer cachexic mice.
- Published in:
- OncoTargets & Therapy, 2012, v. 5, p. 343, doi. 10.2147/OTT.S36119
- By:
- Publication type:
- Article
Research progress on criteria for discontinuation of EGFR inhibitor therapy.
- Published in:
- OncoTargets & Therapy, 2012, v. 5, p. 263, doi. 10.2147/OTT.S36103
- By:
- Publication type:
- Article
A study of mifepristone/IFN-γ-induced apoptosis of human cholangiocarcinoma cell line FRH-0201 in vitro.
- Published in:
- OncoTargets & Therapy, 2012, v. 5, p. 335, doi. 10.2147/OTT.S36098
- By:
- Publication type:
- Article
Bid-overexpression regulates proliferation and phosphorylation of Akt and MAPKs in response to etoposide-induced DNA damage in hepatocellular carcinoma cells.
- Published in:
- OncoTargets & Therapy, 2012, v. 5, p. 279, doi. 10.2147/OTT.S36087
- By:
- Publication type:
- Article
Helical tomotherapy provides efficacy similar to that of intensity-modulated radiation therapy with dosimetric benefits for endometrial carcinoma.
- Published in:
- OncoTargets & Therapy, 2012, v. 5, p. 245, doi. 10.2147/OTT.S35958
- By:
- Publication type:
- Article
Extramedullary plasmacytoma in the presence of multiple myeloma: clinical correlates and prognostic relevance.
- Published in:
- OncoTargets & Therapy, 2012, v. 5, p. 329, doi. 10.2147/OTT.S35348
- By:
- Publication type:
- Article
Weekly paclitaxel, gemcitabine, and external irradiation followed by randomized farnesyl transferase inhibitor R115777 for locally advanced pancreatic cancer.
- Published in:
- OncoTargets & Therapy, 2012, v. 5, p. 161, doi. 10.2147/OTT.S33560
- By:
- Publication type:
- Article
The utility of tumor markers CA 125, CA 15-3, and CA 19-9 in assessing the response to therapy in pulmonary and pleural tuberculosis.
- Published in:
- OncoTargets & Therapy, 2012, v. 5, p. 385, doi. 10.2147/OTT.S32888
- By:
- Publication type:
- Article
Efficacy of sorafenib after liver transplantation in patients with primary hepatic carcinoma exceeding the Milan criteria: a preliminary study.
- Published in:
- OncoTargets & Therapy, 2012, v. 5, p. 457, doi. 10.2147/OTT.S31387
- By:
- Publication type:
- Article
Denosumab: a new option in the treatment of bone metastases from urological cancers.
- Published in:
- OncoTargets & Therapy, 2012, v. 5, p. 221, doi. 10.2147/OTT.S30578
- By:
- Publication type:
- Article
Bevacizumab in the treatment of five patients with breast cancer and brain metastases: Japan Breast Cancer Research Network-07 trial.
- Published in:
- OncoTargets & Therapy, 2012, v. 5, p. 185, doi. 10.2147/OTT.S36515
- By:
- Publication type:
- Article
Crosstalk between EGFR and integrin affects invasion and proliferation of gastric cancer cell line, SGC7901.
- Published in:
- OncoTargets & Therapy, 2012, v. 5, p. 271, doi. 10.2147/OTT.S35322
- By:
- Publication type:
- Article
Carfilzomib: a novel treatment in relapsed and refractory multiple myeloma.
- Published in:
- OncoTargets & Therapy, 2012, v. 5, p. 237, doi. 10.2147/OTT.S28911
- By:
- Publication type:
- Article
Survivin splice variants are not essential for mitotic progression or inhibition of apoptosis induced by doxorubicin and radiation.
- Published in:
- OncoTargets & Therapy, 2012, v. 5, p. 7, doi. 10.2147/OTT.S28147
- By:
- Publication type:
- Article
Targeted treatments for cervical cancer: a review.
- Published in:
- OncoTargets & Therapy, 2012, v. 5, p. 315, doi. 10.2147/OTT.S25123
- By:
- Publication type:
- Article
Current and emerging treatment options for nasopharyngeal carcinoma.
- Published in:
- OncoTargets & Therapy, 2012, v. 5, p. 297, doi. 10.2147/OTT.S28032
- By:
- Publication type:
- Article
Recombinant human decorin suppresses liver HepG2 carcinoma cells by p21 upregulation.
- Published in:
- OncoTargets & Therapy, 2012, v. 5, p. 143, doi. 10.2147/OTT.S32918
- By:
- Publication type:
- Article
The effect of anti-VEGF drugs (bevacizumab and aflibercept) on the survival of patients with metastatic colorectal cancer (mCRC).
- Published in:
- OncoTargets & Therapy, 2012, v. 5, p. 59, doi. 10.2147/OTT.S29719
- By:
- Publication type:
- Article
Potential use of STAT3 inhibitors in targeted prostate cancer therapy: future prospects.
- Published in:
- OncoTargets & Therapy, 2012, v. 5, p. 119, doi. 10.2147/OTT.S32559
- By:
- Publication type:
- Article
Evaluation of therapeutic effect of tumor-targeted therapy.
- Published in:
- OncoTargets & Therapy, 2012, v. 5, p. 191, doi. 10.2147/OTT.S36307
- By:
- Publication type:
- Article
The role of EGFR-targeting strategies in the treatment of head and neck cancer.
- Published in:
- OncoTargets & Therapy, 2012, v. 5, p. 127, doi. 10.2147/OTT.S31863
- By:
- Publication type:
- Article
Vorinostat approved in Japan for treatment of cutaneous T-cell lymphomas: status and prospects.
- Published in:
- OncoTargets & Therapy, 2012, v. 5, p. 67, doi. 10.2147/OTT.S23874
- By:
- Publication type:
- Article
Targeting bladder tumor cells in voided urine of Chinese patients with FITC-CSNRDARRC peptide ligand.
- Published in:
- OncoTargets & Therapy, 2012, v. 5, p. 85, doi. 10.2147/OTT.S31368
- By:
- Publication type:
- Article
Treatment with transcatheter arterial chemoembolization induces an increase of the L-selectin<sub>low</sub> CXCR3+ CD8+ T cell subset in patients with hepatocellular carcinoma.
- Published in:
- OncoTargets & Therapy, 2012, v. 5, p. 103, doi. 10.2147/OTT.S31816
- By:
- Publication type:
- Article
Safety profiles of current antiangiogenic therapies for metastatic colorectal cancer.
- Published in:
- OncoTargets & Therapy, 2012, v. 5, p. 133, doi. 10.2147/OTT.S31412
- By:
- Publication type:
- Article
Application of reticulated platelets to transfusion management during autologous stem cell transplantation.
- Published in:
- OncoTargets & Therapy, 2012, v. 5, p. 1, doi. 10.2147/OTT.S27883
- By:
- Publication type:
- Article
Targeted therapy for esophagogastric cancers: a review.
- Published in:
- OncoTargets & Therapy, 2012, v. 5, p. 91, doi. 10.2147/OTT.S25117
- By:
- Publication type:
- Article
Suppression of human breast tumors in NOD/SCID mice by CD44 shRNA gene therapy combined with doxorubicin treatment.
- Published in:
- OncoTargets & Therapy, 2012, v. 5, p. 77, doi. 10.2147/OTT.S30609
- By:
- Publication type:
- Article
Axitinib for the treatment of patients with advanced metastatic renal cell carcinoma (mRCC) after failure of prior systemic treatment.
- Published in:
- OncoTargets & Therapy, 2012, v. 5, p. 111, doi. 10.2147/OTT.S23273
- By:
- Publication type:
- Article
Emerging treatment options for patients with recurrent advanced thymic epithelial tumors.
- Published in:
- OncoTargets & Therapy, 2012, v. 5, p. 177, doi. 10.2147/OTT.S23267
- By:
- Publication type:
- Article
Hedgehog pathway as a drug target: Smoothened inhibitors in development.
- Published in:
- OncoTargets & Therapy, 2012, v. 5, p. 47, doi. 10.2147/OTT.S21957
- By:
- Publication type:
- Article
Treatment of advanced pancreatic neuroendocrine tumors: potential role of everolimus.
- Published in:
- OncoTargets & Therapy, 2012, v. 5, p. 217, doi. 10.2147/OTT.S16289
- By:
- Publication type:
- Article
Expression of transient receptor potential channel 6 in cervical cancer.
- Published in:
- OncoTargets & Therapy, 2012, v. 5, p. 171, doi. 10.2147/OTT.S33550
- By:
- Publication type:
- Article
Treating metastatic soft-tissue or bone sarcomas - potential role of ridaforolimus.
- Published in:
- OncoTargets & Therapy, 2012, v. 5, p. 153, doi. 10.2147/OTT.S19055
- By:
- Publication type:
- Article